Overlook Medical Center’s Atlantic Neuroscience Institute is in the MIND trial: A Prospective, Multicenter Study of Artemis™ a Minimally Invasive Neuro Evacuation Device, in the Removal of Intracerebral Hemorrhage.

The study is designed to compare the safety and efficacy of the Artemis Neuro Evacuation Device to best medical management in evacuating intracerebral hemorrhage in eligible patients. Paul Saphier, MD, serves as the lead investigator for the local arm of the study. Dr. Saphier is an endovascular neurosurgeon at Overlook Medical Center’s Atlantic Neuroscience Institute, part of Atlantic Health System Neuroscience, and at Atlantic Neurosurgical Specialists, an independent physician practice. The study is sponsored by Penumbra, Inc.

“Our interventionalist team has performed approximately 100 of these procedures using the Artemis™ device and Penumbra’s prior generation device over a two-year period,” according to Dr. Saphier. “We are proud to be a major participant in this trial, as well as many others, that provide a benefit to our patients.”

Sign Up for Berkeley Heights Newsletter
Our newsletter delivers the local news that you can trust.

Intracerebral hemorrhage is a life-threatening kind of stroke which occurs when a diseased blood vessel within the brain bursts, allowing blood to leak inside the brain. The sudden increase in pressure within the brain can cause damage to the brain cells surrounding the blood.

The Artemis device is inserted with the endoscope into a small incision to the affected area of the brain.  The Artemis device removes the clot through its cannula using suction, powered by a proprietary external vacuum source . The team at Overlook Medical Center is trained to use the device in conjunction with other equipment in the operating room, such as navigation, endoscope, and other devices.

MIND is a prospective, multicenter randomized controlled clinical trial in adult patients with an intracerebral hemorrhage. Eligible patients must be 18 to 80 years old with an intracerebral hemorrhage. Patients will be randomized to receive either medical management with the Artemis™ device or medical management alone. Twice as many patients will receive medical management with the Artemis™ device. Learn more about the study inclusion and exclusion criteria.

For information about patient enrollment, please contact the Overlook Medical Center neuroscience department at 908-522-6394 or email research@atlantichealth.org.

 

About Atlantic Health System Neuroscience

Atlantic Health System Neuroscience, anchored at Overlook Medical Center’s Atlantic Neuroscience Institute, with active programs at Morristown, Newton, Chilton and Hackettstown Medical Centers, is the region’s leader in neuroscience care.

Atlantic Health System Neuroscience, working with Atlantic Mobile Health, was the first in the nation to deploy and use portable TeleStroke technology in ambulances for routine pre-hospital assessment of stroke patients. Stroke neurologists at Overlook Medical Center also provide neurological evaluations via TeleStroke devices deployed in emergency departments across six counties. In 2018, out of 2638 stroke patients treated at Atlantic Health System, 795 were evaluated through TeleStroke technology.

Atlantic Health System’s most complex stroke patients are treated at Overlook Medical Center’s Joint Commission-certified Comprehensive Stroke Center, a designation reserved for approximately 180 hospitals in the United States. Overlook is the only hospital in New York and New Jersey named as one of Healthgrades® America’s 100 Best Hospitals for Stroke Care™ for six years in a row (2014-2019).

Overlook Medical Center, with a helipad dedicated to emergency neurological patient transport, as well as a Neuro-ICU and 29-bed neuroscience inpatient unit, has established centers of excellence in the areas of brain tumor, concussion and traumatic brain injury, cerebrovascular disease, including stroke and aneurysm, epilepsy, memory and cognitive disorders, including Alzheimer’s disease, movement disorders, including Parkinson’s disease, neuromuscular disease, pain and headache, and spine disorders.

Overlook Medical Center is named by Healthgrades® among the Top 5% in the nation for both Neurosciences and for Cranial Neurosurgery.  CareChex®, a medical quality rating system that reviews hospital clinical quality, patient safety and performance of nearly all acute care hospitals and health systems in the U.S., ranked Overlook Medical Center as number one in New Jersey and Top 100 in the nation for Medical Excellence and Patient Safety in Major Neurosurgery.

About Atlantic Health System

Atlantic Health System, headquartered in Morristown, N.J., is an integrated health care delivery system powered by a workforce of more than 16,800 team members and 4,800 affiliated physicians dedicated to building healthier communities. The system serves a population of 5 million, with more than 400 sites of care, including six hospitals: Morristown Medical Center, Overlook Medical Center, Newton Medical Center, Chilton Medical Center, Hackettstown Medical Center and Goryeb Children’s Hospital.

In addition to the employed workforce, Atlantic Alliance, a Clinically Integrated Network, represents more than 2,500 health care providers throughout northern and central NJ. This network includes 1,000 physicians and providers within the Atlantic Medical Group, as well as members of the Atlantic Accountable Care Organization and Optimus Healthcare Partners which work to enhance patient care delivery.

Atlantic Health System provides care for the full continuum of health care needs including 12 urgent care centers, Atlantic Rehabilitation and Atlantic Home Care and Hospice. Facilitating the connection between these services on both land and air is the transportation fleet of Atlantic Mobile Health.

Atlantic Health System leads the Healthcare Transformation Consortium, a partnership of seven regional hospitals and health systems dedicated to improving access and affordability and is a founding member of both the PIER Consortium – Partners in Innovation, Education, and Research – a streamlined clinical trial system that will expand access to groundbreaking research across six health systems in New Jersey and Pennsylvania -- and AllSpire Health Partners, a consortium of five leading health care organizations dedicated to serving patients, families and communities in New Jersey, New York, Maryland and Pennsylvania.

About Penumbra Artemis™ Neuro Evacuation Device

The Artemis Neuro Evacuation Device is used for the controlled aspiration of tissue and/or fluid during surgery of the Ventricular System or Cerebrum in conjunction with a Penumbra Aspiration Pump. For more information see www.penumbrainc.com.